Syndax Pharmaceuticals saw the highest growth of 0.99% in patent filings in April and 0.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Syndax Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Syndax Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 33% of grants. The South Korea(KR), Chile(CL), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Syndax Pharmaceuticals is filings its patents. Among the top granted patent authorities, Syndax Pharmaceuticals has 33% of its grants in European Patent Office(EPO), 33% in Israel(IL) and 33% in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Syndax Pharmaceuticals
Patents related to rare diseases lead Syndax Pharmaceuticals's portfolio
Syndax Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Non-small cell lung cancer related patents lead Syndax Pharmaceuticals portfolio followed by melanoma, and breast cancer
Syndax Pharmaceuticals has highest number of patents in non-small cell lung cancer followed by melanoma, breast cancer, lung cancer, and ovarian cancer.
For comprehensive analysis of Syndax Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
